Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK/PD of AZD9898 in Healthy Volunteers and Asthma Patients
NCT03140072Phase 1Terminated
- Sponsor
- AstraZeneca
- Start
- May 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in asthma comparing AZD9898 with Placebo (2 arms). Primary endpoints: Number of patients with Adverse Events (AEs), Vital sign (Blood pressure [BP]) and 6 more. Started May 2017; status: terminated.
02
Drugs
AZD9898
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03140072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140072.